ISRCTN38534743已完成不适用
Selenium supplementation for the prevention of hepatocellular carcinomas in HBsAg positive patients (pilot study)
The University of Birmingham (UK)0 个研究点目标入组 0 人开始时间: 2003年9月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •Participants will include:
- •1. Men aged 45 to 64 with positive HBsAg (hepatitis B surface antigen) test
- •2. Negative AFP (alphafetoprotein) test
- •3. Normal ALT (alanine aminotransferase) values
排除标准
- •Not provided at time of registration
研究者
相似试验
招募中
3 期
The Effect of Selenium Supplement on subclinical Hypothyroidism in childreIRCT20220314054284N1Gorgan University of Medical Sciences148
已完成
2 期
Investigation of the effect of Selenium in beta thalassemia majorthalassemia major.Beta thalassemiaD56.1IRCT20180603039959N3Ahvaz University of Medical Sciences42
Unknown
不适用
Selenium biofortification intervention in central Kenya highlandsPACTR201710002698231Meru University of Science & Technology180
已完成
2 期
The effect of selenium on nephropathy complications of diabetic patientsnon-insulin-dependent diabetes mellitus with renal complicationsE11.2diabetic nephropathy.IRCT2015060622562N1Vice chancellor for research, Kashan University of Medical Sciences60
尚未招募
2 期
The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control groupIRCT20160706028815N5Sabzevar University of Medical Sciences40